Background illustration for clinical trials search

Paid Clinical Trials Fort Worth

Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
New

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Dallas TX, Austin TX, San Antonio TX, Nashville TN,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07542704

Phase 1, Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumor
Location: Fort Worth TX, Austin TX, Grand Rapids MI,
Sponsor: Pliant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06270706

Phase 1, Recruiting

First In Human Study of CX-801 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Fort Worth TX, Englewood CO, Nashville TN,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06462794

Phase 1, Recruiting

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Fort Worth TX, Indianapolis IN, Sarasota FL,
Sponsor: InduPro, Inc.

Sex: All

Age: 18+

Code: NCT07602842

Phase 1, Phase 2, Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for
Esophageal Squamous Cell Carcinoma,
Location: Fort Worth TX, Irving TX, Austin TX, San Antonio TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07503808

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Dallas TX, San Antonio TX, Houston TX, New Orleans LA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07080242

Phase 1, Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

for
Cancer
Location: Fort Worth TX, Dallas TX, Austin TX, San Antonio TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18 - 70+

Code: NCT07540572

Phase 1, Recruiting

First In Human Study of CX-2051 in Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Fort Worth TX, San Antonio TX, Denver CO, Nashville TN,
Sponsor: CytomX Therapeutics

Sex: All

Age: 18+

Code: NCT06265688

Phase 1, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Fort Worth TX, Tyler TX, Austin TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase 3, Recruiting

Multi-Institutional Registry for Prostate Cancer Radiosurgery

for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Fort Worth TX, Dallas TX, Tyler TX, Austin TX,
Sponsor: RPCR, Inc.

Sex: Male

Age: 18 - 70+

Code: NCT01226004

Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

for
Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma,
Location: Forth Worth TX, Dallas TX, Shreveport LA,
Sponsor: Guardant Health, Inc.

Sex: All

Age: 18+

Code: NCT05059444

Recruiting

Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies

for
Advanced Malignancies
Location: Fort Worth TX, Irving TX, Houston TX, Fairfax VA,
Sponsor: PharmaMar

Sex: All

Age: 18+

Code: NCT07644039

Phase 1, Phase 2, Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: Fort Worth TX, San Antonio TX, Houston TX, St Louis MO,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase 2, Recruiting

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

for
Non Small Cell Lung Cancer (Squamous or Non Squamous),
Location: Fort Worth TX, Albuquerque NM, Pueblo CO, Daphne AL,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT07365319

Phase 2, Phase 3, Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Fort Worth TX, Denton TX, Tyler TX, Austin TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07361497

Phase 3, Recruiting

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Fort Worth TX, West Valley City UT, Los Angeles CA
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07517198

Phase 1, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: Arlington TX, Fort Worth TX, Burleson TX,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase 3, Recruiting

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

for
HER2-positive Breast Cancer
Location: Fort Worth TX, Austin TX, Germantown TN, Huntsville AL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07413939

Phase 2, Phase 3, Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Fort Worth TX, Houston TX, Plantation FL, Tamarac FL,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT07262619

Phase 1, Phase 2, Recruiting

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

for
Colorectal Cancer
Location: Fort Worth TX, Grapevine TX, Austin TX, Houston TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07023289

Phase 2, Recruiting